Search results
Get Ready for NBA Players to Make $100 Million a Year
The Wall Street Journal· 3 hours agoThat fresh round of media contracts is laying the foundation for players to cash in with blockbuster...
It's Unlikely That The CEO Of Veracyte, Inc. (NASDAQ:VCYT) Will See A Huge Pay Rise This Year
Simply Wall St. via Yahoo Finance· 49 minutes agoWe did our research and spotted 1 warning sign for Veracyte that investors should look into moving...
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
InvestorPlace· 14 hours agoOne of the most important sectors globally, it is hard to imagine life without biotech companies...
Wait, what? Is Dogfish Head getting bought by a Japanese whisky company?: WSJ
Delaware Online | The News Journal via Yahoo Finance· 3 hours agoBeer's finances? Why is there so speculation surrounding its potential sale? Boston Beer ended the...
Here's Why Shareholders May Want To Be Cautious With Increasing Genting Malaysia Berhad's...
Simply Wall St. via Yahoo Finance· 14 hours agoImportant note: Genting Malaysia Berhad is an exciting stock, but we understand investors may be...
Nvidia Just Announced a 10-for-1 Stock Split in June. This Artificial Intelligence (AI) Stock Could...
Motley Fool via Yahoo Finance· 5 days agoNvidia (NASDAQ: NVDA) reported blockbuster results for the first quarter. Revenue more than tripled...
Most Shareholders Will Probably Agree With BioCryst Pharmaceuticals, Inc.'s (NASDAQ:BCRX) CEO...
Simply Wall St. via Yahoo Finance· 2 hours agothat you should be aware of before investing here. Important note: BioCryst Pharmaceuticals is an...
Shareholders Will Likely Find Mammoth Energy Services, Inc.'s (NASDAQ:TUSK) CEO Compensation...
Simply Wall St. via Yahoo Finance· 2 hours agoAlthough we don't have analyst forecasts, you might want to assess this data-rich visualization of...
Shareholders Will Most Likely Find DICK'S Sporting Goods, Inc.'s (NYSE:DKS) CEO Compensation...
Simply Wall St. via Yahoo Finance· 2 hours agoImportant note: DICK'S Sporting Goods is an exciting stock, but we understand investors may be...
Why CEO AstraZeneca believes the drugmaker can almost double revenue by 2030
CNBC· 2 days agoAstraZeneca CEO Pascal Soriot explained in a Tuesday interview with CNBC's Jim Cramer why the...